Healthcare service utilisation costs attributable to rheumatoid arthritis in France: Analysis of a representative national claims database - 07/01/16
, Gabrielle Cukierman c, Jean-Michel Joubert c, Caroline Laurendeau d, Julie Gourmelen e, Francis Fagnani dBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objective |
To estimate healthcare service utilisation costs of patients with rheumatoid arthritis in France and to estimate the fraction of these costs attributable to RA.
Method |
The “Échantillon généraliste des bénéficiaires” (EGB) is a 1/97 random sample of the main national claims database covering the French population. A cohort of patients with rheumatoid arthritis was constituted of all adults benefiting from full coverage for rheumatoid arthritis (ICD-10 M05-06) on 1st january 2009. A control group matched for age and gender was identified. Health expenditures were assessed from the payer's perspective for the year 2010.
Results |
The annual per capita reimbursed total health expenditure was €6,404 in 2010, an amount around two times higher than in the control group €3,095 (P<0.0001). The main contributors to this extra cost were outpatient care (+€2,407; 72.7%), including medication (+€1,686; 50.0%), and inpatient care (+€903; 27.3%). Patients treated by biological agents generated an age-adjusted per capita annual expenditure about three times higher than untreated patients (€15,757 versus €4,640).
Conclusion |
Only half of medical expenditure by patients with rheumatoid arthritis is attributable to their disease and use of biological agents has become a major driver of cost.
Le texte complet de cet article est disponible en PDF.Keywords : Cost, Rheumatoid arthritis, Biological agents, France
Plan
Vol 83 - N° 1
P. 53-56 - janvier 2016 Retour au numéro
Article précédent
- Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study
- Philippe Bertin, Francis Fagnani, Anne Duburcq, Anne-Sophie Woronoff, Pierre Chauvin, Gabrielle Cukierman, Sonia Tropé-Chirol, Jean-Michel Joubert, Gisela Kobelt
- Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort
- Giovanni Matarese, Gaetano Isola, Angela Alibrandi, Alberto Lo Gullo, Gianluca Bagnato, Giancarlo Cordasco, Letizia Perillo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?